United States  

Cancer Scare Triggers GSK To Pull Popular OTC Heartburn Med

Video Credit: Wochit - Duration: 00:36s - Published
Cancer Scare Triggers GSK To Pull Popular OTC Heartburn Med

Cancer Scare Triggers GSK To Pull Popular OTC Heartburn Med

Reuters reports GlaxoSmithKline is recalling the popular heartburn medicine Zantac in all markets.

The pharmaceutical giant said it was doing so as a “precaution." The announcement came days after the U.S. Food and Drug Administration found “unacceptable” levels of probable cancer-causing impurity in the drug.

Zantac is also sold generically as ranitidine.

It's latest drug in which cancer-causing impurities have been found.


You Might Like


Tweets about this